MicroStent
Phase 3- Indications
- Critical Limb Ischemia, Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease
Company intelligence / Profile preview
Micro Medical Solutions develops minimally invasive devices to treat peripheral artery disease and critical limb ischemia. Their technology aims to reduce amputation rates by improving blood flow in microvascular beds of the lower limbs. The company has filed patents related to these interventions and reports improved clinical outcomes and reduced treatment costs for patients with PAD/CLI. Specific published clinical trial results are not detailed in public sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Micro Medical Solutions.